Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

INmune Bio Inc. - Common stock (NQ:INMB)

1.310 -0.040 (-2.96%)
Streaming Delayed Price Updated: 1:53 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about INmune Bio Inc. - Common stock

< Previous 1 2 3 4 5 Next >
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
What to Expect from INmune Bio's Earnings ↗
 
Via Benzinga
News headline image
INmune Bio: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
A Preview Of INmune Bio's Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 27, 2025 ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Earnings Outlook For INmune Bio ↗
 
Via Benzinga
News headline image
INmune Bio's Earnings Outlook ↗
 
Via Benzinga
News headline image
INmune Bio Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
Earnings Preview: INmune Bio ↗
 
Via Benzinga
News headline image
C-Suite Buy of the Week: Executive Moves from Biotech to Banking ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q1 2024 ↗
INMB stock results show that INmune Bio missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023 ↗
INMB stock results show that INmune Bio missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Why Is Elevai Labs (ELAB) Stock Up Today? ↗
Elevai Labs is soaring on an intriguing licensing agreement with INmune Bio, but the narrative presents a mixed bag for ELAB stock. 
Via InvestorPlace
News headline image
Why Elevai Labs Stock Is Trading Higher ↗
Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune... 
Via Benzinga
News headline image
INmune Bio's INKmune Shows Positive Efficacy In Multiple Cancer Cell Lines ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 28, 2024 ↗
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning! 
Via InvestorPlace
News headline image
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning ↗
Biotech companies are edging closer to finding the answers behind Alzheimer's disease. 
Via Investor's Business Daily
News headline image
INmune Bio – Helping Your Own Cells Fight Cancer And Reverse Alzheimer's Disease ↗
David Moss, CEO of INmune Bio (NASDAQ: INMB) was recently a guest on Benzinga’s All-Access. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2023 ↗
 
Via Benzinga
News headline image
The 7 Best Biotech Stocks for Personalized Medicine Investors ↗
Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics. 
Via InvestorPlace
News headline image
Dow Jumps 250 Points; US Jobless Claims Increase Last Week ↗
U.S. stocks traded higher this morning, with the Dow Jones jumping around 250 points on Thursday. The Dow traded up 0.75% to 34,204.99 while the NASDAQ rose 1.15% to 12,047.28. The S&P 500 also rose,... 
Via Benzinga
News headline image
Nasdaq Tumbles 150 Points; Crude Oil Up 1.5% ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 150 points on Wednesday. The Dow traded down 0.27% to 34,063.42 while the NASDAQ fell 1.33% to 11,952.51. The... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Recap: INmune Bio Q2 Earnings ↗
INmune Bio (NASDAQ:INMB) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings INmune Bio beat estimated... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.